Factor V Leiden News and Research

RSS
Anticardiolipin antibodies and COVID-19

Anticardiolipin antibodies and COVID-19

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

African Americans with common genetic variants at increased risk for blood clots

African Americans with common genetic variants at increased risk for blood clots

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Blood type, blood protein mutations influence thromboembolism risk

Blood type, blood protein mutations influence thromboembolism risk

Non-O blood type - the most important risk factor for venous thromboembolism

Non-O blood type - the most important risk factor for venous thromboembolism

Hypercoagulable markers identified in upper arm thrombosis patients

Hypercoagulable markers identified in upper arm thrombosis patients

Low blood anticoagulant levels increase risk for VTE

Low blood anticoagulant levels increase risk for VTE

Women can have successful pregnancy after recurrent miscarriage

Women can have successful pregnancy after recurrent miscarriage

Increased blood clotting tendency linked to elevated bowel cancer risk

Increased blood clotting tendency linked to elevated bowel cancer risk

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Risk, incidence of VTE differs between races

Risk, incidence of VTE differs between races

FVL gene mutation increases risk of blood clots in breast cancer patients treated with tamoxifen: Study

FVL gene mutation increases risk of blood clots in breast cancer patients treated with tamoxifen: Study

FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

FDA clears Osmetech's eSensor Thrombophilia Risk Test

FDA clears Osmetech's eSensor Thrombophilia Risk Test

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid receives approval to market Xpert(R) HemosIL(R) FII & FV test

Cepheid receives approval to market Xpert(R) HemosIL(R) FII & FV test

Abdominal venous thrombosis risk factors

Abdominal venous thrombosis risk factors

Migraine sufferers more at risk of deadly blood clots

Migraine sufferers more at risk of deadly blood clots

Warfarin may prevent liver failure in hepatitis C

Warfarin may prevent liver failure in hepatitis C